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1. Executive summary  
The health issues that have received the most consistent attention in G7 and G20 summit 
declarations, having been addressed in more than half of the summits since 2015 and appearing 
in 30 or more commitments over that time, are: 
 Health systems strengthening  
 Infectious diseases (including HIV/AIDS, tuberculosis, malaria, polio, neglected tropical 
diseases, and vaccination) 
 Antimicrobial resistance (AMR)  
 Public health crises (including emergency preparedness and response, global health 
security, global health architecture, International Health Regulations, pandemics, Ebola, 
and Zika) 
Other issues highlighted in at least half of the summits include the importance of the One Health 
approach and multisectoral working (particularly in the context of combating antimicrobial 
resistance), research and development (in the context of work on infectious diseases and 
antimicrobial resistance), and universal health coverage. 
G7 and G20 summit declarations have tended to neglect non-communicable diseases, 
environmental pollution, tobacco control, substance abuse, road traffic morbidity and mortality, 
access to essential medicines via the Agreement on Trade-Related Aspects of Intellectual 
Property Rights (TRIPS), and social issues such as equity and the social determinants of health 
(Kirton & Bracht, 2015; McBride et al., 2019). 
G7 health commitments are closely aligned with Sustainable Development Goal 3, with 
commitments corresponding to 24 out of the 28 targets and principles in SDG 3.  The G20’s 
commitments on health are less well aligned to SDG 3, matching only 14 of the 28 targets and 
principles (McBride et al., 2019). 
Some authors have criticised G7 and G20 health commitments for not being specific or 
measurable enough to hold member states to account effectively (Kirton & Bracht, 2015; Horton, 
2017; McBride et al., 2019). 
The G7 and G20 both refer to inclusiveness in the form of supporting work towards universal 
health coverage, although this is more prevalent for the G7 than for the G20.  The G7 included 
specific references to women’s and girls’ health among their commitments, while no specific 
references to gender were noted in G20 health-related commitments.  No specific references to 
disability were observed in the summit documents reviewed for this report. 
2. Methodology and scope 
This analysis draws heavily on work done by the G7 and G20 Research Groups at the University 
of Toronto, Canada, which have compiled lists of G71 and G20 summit commitments for many 
years following a consistent methodology (Kirton, Kokotsis, Guebert, & Bracht, 2016).  These 
                                                   
1 The G7 was known as the G8 from 1997 to 2014, when Russia was a member.  Russia was suspended in 
2014. This report focuses on the period from 2014 through 2019, so it refers to the G7, but draws on sources that 
may take a longer perspective and so may refer to the G8 when discussing years prior to 2014. 
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data include the commitments made in the Leaders’ Declarations or Communiqués and other 
core high-level documents agreed at each summit.  Each commitment may refer to one or more 
specific health issue, which have been grouped together using a classification scheme that was 
designed and adapted to match the range of issues addressed in the documents.   
Health ministers’ meetings were also convened alongside the G7 summits in 2015, 2016, 2017, 
and 2019, and the G20 summits in 2017 and 2018.  The declarations or communiqués coming 
from the health ministers’ meetings tend to reiterate the high-level priorities agreed at the 
summit, while providing additional detail about specific initiatives to be supported or actions to be 
taken.  For the purposes of this report, the main summit declarations or communiqués were 
assumed to be the best representation of high-level agreement on the top priority issues, so the 
health ministerial meeting communiqués were not analysed. 
3. G7 and G20 commitments on health, 2015-2019 
The attention placed on health in general at G7 and G20 summits, and the degree of focus on 
individual health issues more specifically, varies a great deal from year to year.  At the G20 
meeting in 2015 (Antalya) the leaders’ communiqué only addressed health with the general 
statement that “attention should be given to global health risks, such as antimicrobial resistance, 
infectious disease threats and weak health systems” (G20, 2015).  At the G20 meeting in 2016 
(Hangzhou), the only health issue mentioned in the summit declaration was antimicrobial 
resistance (Warren, 2016).  On the other hand, the G7 meeting of 2016 (Ise-Shima) featured 
health very strongly, so that with the G7 Ise-Shima Vision for Global Health supplementing the 
usual Leaders’ Declaration, one-quarter of all the text agreed upon at the summit, by word count, 
was related to health (Kirton et al., 2019). 
The health issues that have received the most consistent attention in G7 and G20 summit 
declarations, having been addressed in more than half of the summits since 2015 and appearing 
in 30 or more commitments over that time, are (see Table 1 below for a summary, and 
Appendices A and B for the text of commitments): 
 Health systems strengthening  
 Infectious diseases (including HIV/AIDS, tuberculosis, malaria, and polio, neglected 
tropical diseases, and vaccination) 
 Antimicrobial resistance (AMR) 
 Public health crises (including emergency preparedness and response, global health 
security, global health architecture, International Health Regulations, pandemics, Ebola, 
and Zika) 
Other issues highlighted in at least half of the summits include support for the One Health 
approach2 and multisectoral working (particularly in the context of combating antimicrobial 
resistance), research and development (in the context of work on infectious diseases and 
antimicrobial resistance), and universal health coverage. 
                                                   
2 ‘One Health is an approach to designing and implementing programmes, policies, legislation and research in 
which multiple sectors communicate and work together to achieve better public health outcomes.’  It particularly 
links food safety, the control of zoonoses, and combating antibiotic resistance. 
(https://www.who.int/features/qa/one-health/en/) 
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Table 1: G7 and G20 summit commitments on health, 2015-2019 
Numbers within the table are the number of times each issue was mentioned in summit documents.  Some commitments refer to more than one issue.  Highlighted rows 
indicate the issues with the most consistent support. 
 G7 G20 
 2019  
(Biarritz) 
2018 
(Charlevoix) 
2017 
(Taormina) 
2016 
(Ise-
Shima) 
2015 
(Schloss 
Elmau) 
2019  
(Osaka) 
2018 
(Buenos 
Aires) 
2017 
(Hamburg) 
2016 
(Hangzhou) 
2015 
(Antalya) 
Antimicrobial resistance (AMR)  1  23 31 2  11 3 1 
Disaster risk reduction and 
disaster response  
   1       
Health systems strengthening  1 1 1 17 3 2 1 3  1 
Healthy and active ageing (including 
dementia) 
   5 0 4 0 0 0 0 
Infectious diseases (including 
HIV/AIDS, tuberculosis, malaria, and 
polio, neglected tropical diseases, and 
vaccination) 
1 3  12 18 3 1 1  1 
Mental health   1 1 1  1     
Non-communicable diseases 
(including malnutrition, overweight, and 
obesity) 
   3 2 1 1    
One Health approach / 
multisectoral working (including One 
Health approach, agriculture, 
environment, and food safety) 
 1  4 4 1 0 4   
Primary health care (including social 
determinants of health)  
1   1  2     
Public health security/crises 
(including emergency preparedness and 
response, global health security, global 
health architecture, International Health 
Regulations, pandemics, Ebola, and Zika) 
 1 3 26 7 4 1 5   
5 
Reproductive, maternal, newborn, 
child, and adolescent health 
(RMNCAH) 
 1  9 3      
Research and development  0 0 0 12 20 2  1 1  
Universal health coverage (including 
equity, access, and leave no-one behind) 
1 1 0 20 1 0 1    
Women's and girls' health 2 1  6       
Other non-specific goals (including 
general expressions of support for health 
and for the SDGs) 
  2 5 1     1 
Sources: Bracht, 2015; Warren, 2016; Warren, 2017; Warren, 2018; Warren, 2019; G7, 2019; G7 Research Group, 2019.  
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Other authors’ analyses of G7 and G20 summit declarations show similar conclusions about the 
issues that have emerged as priorities from these summits. 
Examining G7 summits from 2015 and 2017, Missoni et al. (2019) summarise the health-related 
priorities in the first two years as including Ebola, antimicrobial resistance, neglected tropical 
diseases, strengthening response to public health emergencies, and attaining universal 
health coverage with strong health systems and better preparedness, including the One Health 
approach (Missoni et al., 2019, 7.2.1.3).  The authors report that in 2017, ‘the G7 leaders’ final 
communiqué devoted only the last and very generic paragraph to health’ and that the health 
ministers’ meeting which followed the summit ‘mostly reiterated generic commitments and 
support for external initiatives’ although it did also call for work on some issues beyond the health 
sector, including conflict and crisis, social inequalities, globalisation, urbanisation, environmental 
factors, migration and displacement, and gender perspectives on health (Missoni et al., 7.2.1.3). 
Looking at health-related priorities in G20 summits from 2014 through 2017, Missoni et al. (2019) 
summarise the commitments as focused on responding to Ebola and other public health 
crises, health systems strengthening, universal health coverage, and antimicrobial 
resistance including the One Health approach.  They note that although the range of issues 
addressed has broadened over time, ‘the emphasis remains on the response to epidemics and 
ability to control the spread of infectious diseases, while a comprehensive approach to health still 
appears to be lacking’ (Missoni et al., 2019, 7.2.2).   
Similarly, Kickbusch et al. (2018) summarise the G20’s health-related priorities as ‘health 
security, the prevention of pandemics, and systems strengthening.’ 
Some information on members states’ compliance with commitments made at the summits has 
been compiled by the G7 and G20 Research Group at the University of Toronto.  Each year, the 
research groups assess compliance with a small number of the commitments made across all 
policy areas at the previous year’s summit.  Some health-related commitments have been 
included in the assessment process each year, but the commitments selected vary from year to 
year.  Compliance is assessed based on evidence of national government action including 
budgetary allocations, legislation, regulations, and other indicators (Kirton, Kokotsis, Guebert, & 
Bracht, 2016).  The authors’ analysis (summarised in tables 2 and 3 below) shows that 
commitments related to infectious diseases, public health crises, antimicrobial resistance, health 
systems strengthening, and universal health coverage have received strong support, with most 
or all member countries being in full or partial compliance with commitments.  Details of the 
actions taken by each country are available in the reports cited below the tables.  Mental health 
has shown mixed results: in 2017, only one country was found to be complying with the summit 
commitment, but in 2018, all countries were either in full or partial compliance, which may 
suggest increasing interest in the issue. 
Table 2: Number of countries in compliance with selected G7 commitments 
Summit Commitment assessed Full 
compliance 
Partial 
compliance / 
work in 
progress 
2018 
(Charlevoix) 
Mental health: To support growth and equal 
participation that benefits everyone, and ensure our 
citizens lead healthy and productive lives, we commit to 
bringing greater attention to mental health.” 
4 4 
7 
2017  
(Taormina) 
Mental health: [We are committed to pursuing policies 
that advance] mental health [improvements across the 
globe.] 
1 0 
2016  
(Ise-Shima) 
Infectious diseases: We are committed to ending AIDS, 
tuberculosis and malaria, working in partnership with the 
Global Fund (GF) and others. 
6 2 
2016  
(Ise-Shima) 
Public health crises: [Recent outbreaks of Ebola and 
Zika underscore the imperative to improve prevention of, 
detection of and response to public health emergencies, 
whether naturally occurring, deliberate or accidental.] In 
that respect, we remain committed to advancing 
compliance with the WHO’s IHR [International Health 
Regulations] objectives including through the Global 
Health Security Agenda (GHSA). 
3 4 
2015  
(Schloss 
Elmau) 
Infectious diseases: We will stimulate… research 
focused on faster and targeted development of easily 
usable and affordable… vaccines. 
6 1 
2015  
(Schloss 
Elmau) 
Antimicrobial resistance: [We will] effectively 
implement our national action plans 
7 0 
2015  
(Schloss 
Elmau) 
Public health crises: [The G7] will set up or strengthen 
mechanisms for rapid deployment of multidisciplinary 
teams of experts coordinated through a common 
platform. 
6 2 
Sources: Humeniuk et al., 2016; Beard et al., 2017; Bland et al., 2018; Hou et al., 2019 
 
Note: The European Union is a ‘non-enumerated’ member of the G7, so the total number of entities assessed is eight rather 
than seven. 
 
Table 3: Number of countries in compliance with selected G20 commitments 
Summit Commitment assessed Full 
compliance 
Partial 
compliance / 
work in 
progress 
2018  
(Buenos 
Aires) 
Health systems strengthening / Universal Health 
Coverage: We reaffirm the need for stronger health 
systems providing cost effective and evidence-based 
intervention to achieve better access to health care and to 
improve its quality and affordability to move towards 
Universal Health Coverage (UHC), in line with their 
national contexts and priorities. 
17 3 
2017  
(Hamburg) 
Health systems strengthening: We strive for 
cooperative action to strengthen health systems 
worldwide, including through developing the health 
workforce. 
19 1 
Sources: Barnett et al., 2018; Cicci et al., 2019 
4. Issues that may be under-addressed 
McBride et al. (2019, p. 10) suggest that issues that may be under-addressed by the G7 and G20 
include non-communicable diseases (notably diabetes, cardiovascular and respiratory 
diseases, and cancer), environmental pollution, tobacco control, substance abuse (alcohol 
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and narcotics), road traffic morbidity and mortality, and access to essential medicines via the 
Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). Kirton and Bracht 
(2015) agree that the G83 has given ‘very little attention’ to non-communicable diseases.  
McBride et al. (2019, p. 11) also argue that social issues such as equity and the social 
determinants of health have received insufficient attention.  The G7 has included some 
references to environmental health, human rights, and gender equality, which have tended to be 
neglected by the G20.  On the other hand, only the G20 has referred to engaging civil society 
and private sector actors and to the social determinants of health (McBride et al., 2019, p. 10). 
The G7 and G20 both refer to inclusiveness in the form of supporting work towards universal 
health coverage, although this is more prevalent for the G7 than for the G20.  The G7 included 
specific references to women’s and girls’ health among their commitments, while no specific 
references to gender were noted in G20 health-related commitments4.  No specific references to 
disability were observed in the summit documents reviewed for this report. 
5. Alignment of G7/G20 health commitments with SDG 3 
The G7’s health commitments are closely aligned with Sustainable Development Goal 3 (“ensure 
healthy lives and promote well-being for all at all ages”).  McBride at al. (2019) show that G7 
commitments from 2015-2017 include direct commitments to 17 of the 28 targets and principles 
of SDG 3, and weak or indirect references to seven more.  The elements of SDG 3 that are not 
addressed by the G7 are substance abuse (narcotics and alcohol), road traffic injuries, access to 
essential medicines via the Agreement on Trade-Related Aspects of Intellectual Property Rights 
(TRIPS), and the social determinants of health (McBride et al., 2019).  The G20’s health 
commitments are less closely aligned with SDG 3, and either fully or partially cover only 14 of the 
targets and principles of SDG 3, leaving 12 unaddressed (McBride et al., 2019). 
                                                   
3 These authors were writing in 2015, so they refer to the G8, since Russia was a member of the ‘club’ until 2014. 
4 Kulik (2016), looking at how the G7 and G20 address gender more generally, argues that although the G7 has 
recognised women and girl’s rights in its outcome documents, ‘gender equality has largely remained a peripheral 
issue with attention centered on only one particular part of the problem from year to year’ and that ‘the G20 has 
emphasized the economic side of gender issues… [but] attention seems to be fleeting and there is no guarantee 
that gender equality as it relates to economic growth will end up in the communiqué in a meaningful way.’ 
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Figure 1: Correspondence between G7 and G20 summit commitments and SDG 3 targets and principles, 2015-
2017 
 
 
 
Source: McBride et al., 2019, p. 7.  Edited from original image published under Creative Commons Attribution 4.0 International 
License. 
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6. Critiques of summit commitments  
Some authors have criticised the G7 and G20 for formulating commitments that are not specific 
or measurable enough to hold member states to account effectively.  McBride et al. (2019, pp. 
10-11) describe the commitments made by both the G7 and G20 as ‘weak in so far as 
formulating tangible obligations or actions… many of their commitments are described in 
language which does not clearly identify the target of the action… nor do the communiqués 
include concrete measures for reporting or accountability’ (McBride et al., 2019, pp. 10-11).  
Buse (2015, p. 650) criticises the G7 on the grounds that commitments are lacking in ‘specificity 
of targets and means, their future orientation, level of ambition, time-boundedness, the 
bindingness of the obligation and whether commitments apply to those issuing the communiqué 
or other parties, among others’ Richard Horton, editor-in-chief of The Lancet, described the 
G20’s declaration in 2017 as ‘full of platitudes’ but ‘missing one thing – concrete and specific 
actions’ (Horton, 2017, p. 214). 
An exception to the above is noted by Missoni et al. (2019, 7.2.2), who single out the G20’s 2014 
summit declaration as containing ‘specific, measurable, politically binding and long-term 
commitments (concerned with the prevention of future crises rather than just with the 
containment of the ongoing one) rarely seen previously in the relevant documents of the G7 
summits.’ 
Both the G7 and G20 have been criticised for having tendencies to consider health issues from a 
point of view that emphasises economic impacts and growth.  Summit documents often refer to 
economic development as one of the justifications for health-related initiatives (Missoni et al., 
2019, 7.2.2).  Richard Horton, editor-in-chief of The Lancet, argues that the G20’s ‘first and only 
concern is economic growth’ and that when Germany placed global health at the centre of the 
G20’s agenda for the first time, in 2017 at the Hamburg summit, the outcome was a failure 
(Horton, 2017, p. 214).  
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Appendix A: G7 commitments related to health 
Where commitments below are numbered, the numbers are those assigned in reports produced 
by the G7 Research Group at the University of Toronto, Canada. 
2019 (Biarritz, France) 
Source: G7, 2019  
Sahel Partnership Action Plan 
We commit to pursuing our efforts to strengthen quality primary health care in Sahel countries, 
with a specific focus on gender equality and women’s empowerment. We welcome the G7 
Primary Health Care (PHC) Universal Knowledge Initiative adopted by the G7 Health 
Ministers. 
We reaffirm our commitment to end the epidemics of AIDS, tuberculosis and malaria and look 
forward to the success of the Sixth Replenishment of the Global Fund to Fight AIDS, 
Tuberculosis and Malaria. 
We recall our commitment to moving towards achieving universal health coverage according 
to national contexts and priorities, building resilient and sustainable health systems, in order to 
be able to reach the most affected communities. 
We encourage the design of a results-based partnership structure in the field of health and 
human development in pilot countries in sub-Saharan Africa, such as a Development Impact 
Bond for the management of menstrual hygiene in schools. 
2018 (Charlevoix, Canada) 
Source: G7 Research Group, 2019 
Summit Communiqué 
2018-18 To support growth and equal participation that benefits everyone, and ensure our 
citizens lead healthy and productive lives, we commit to supporting strong, 
sustainable health systems that promote access to quality and affordable 
healthcare  
2018-19 [To support growth and equal participation that benefits everyone, and ensure 
our citizens lead healthy and productive lives, we commit to] bringing greater 
attention to mental health.  
2018-20 We support efforts to promote and protect women's health and well-being 
through evidence-based healthcare and health information.  
15 
2018-21 [We support efforts to promote and protect] adolescents' [health and well-being 
through evidence-based healthcare and health information.]  
2018-22 We recommit to support our 76 partners to strengthen their implementation of the 
International Health Regulations, including through their development of costed 
national action plans and the use of diverse sources of financing and multi-
stakeholder resources.  
2018-23 We will prioritize and coordinate our global efforts to fight against antimicrobial 
resistance, in a "one health" approach.  
2018-24 We will accelerate our efforts to end tuberculosis, and its resistant forms.  
2018-25 We reconfirm our resolve to work with partners to eradicate polio and effectively 
manage the post-polio transition.  
2018-26 We affirm our support for a successful replenishment of the Global Fund in 2019.  
2017 (Taormina, Italy) 
Source: G7 Research Group, 2019 
Leaders’ Communiqué 
2017-11  [To achieve this we must improve knowledge and competences across all 
sectors and regions of our countries,] [by investing in fields such as] health, [with 
a view to boosting economic growth and to improving people’s quality of life.]  
2017-67  We are committed to advancing global health security  
2017-68  [We are committed to] pursuing policies that advance physical health 
improvements across the globe  
2017-69  [We are committed to pursuing policies that advance] mental health 
[improvements across the globe.]  
2017-70  We remain committed to strengthening health systems  
2017-71  [We remain committed to strengthening] preparedness for public health 
emergencies and long-term challenges.  
16 
2017-72  [We remain committed to strengthening] a prompt, effective and coordinated 
response to public health emergencies and long-term challenges.  
2016 (Ise-Shima, Japan) 
Source: G7 Research Group, 2019 
Leaders’ Declaration 
2016-13 We commit to take concrete actions for advancing global health as elaborated in 
the G7 Ise-Shima Vision for Global Health, highlighting that health is the 
foundation of economic prosperity and security.  
2016-14 We commit to promote Universal Health Coverage (UHC) as well as endeavor to 
take leadership in reinforcing response to public health emergencies and 
antimicrobial resistance (AMR) which could have serious impacts on our 
economies.  
2016-67 At the juncture of the first G7 summit after the historic adoption of the 2030 
Agenda, we are fully committed to implementing the health-related Sustainable 
Development Goals (SDGs) therein that ensure well-being at all stages and 
health security for all individuals, and foster inclusive economic growth for 
nations.  
2016-68 With these in mind, we particularly commit to take concrete actions in the 
following areas as elaborated in the G7 Ise-Shima Vision for Global Health, as 
set out in the Annex.  
2016-69 We also instruct our Health Ministers to further elaborate necessary actions on 
these areas at their Meeting in Kobe in September.  
2016-70 Reinforcing of the Global Health Architecture to strengthen response to public 
health emergencies Recognizing the Ebola outbreak turned into a major 
epidemic partly due to the lack of swift and coordinated actions among relevant 
stakeholders, we commit to take leadership in reinforcing the Global Health 
Architecture, relying on strengthening existing organizations.  
2016-71 We reaffirm the WHO’s central role in that architecture to enable and support 
more swift, effective and coordinated responses to public health emergencies.  
2016-72 In this light, we urge and support the WHO to implement its emergency and 
wider reforms, including its One WHO approach across the three levels of the 
Organization, namely its headquarters, regional and country offices, in a timely 
manner, recognizing its resource needs.  
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2016-73 [Recent outbreaks of Ebola and Zika underscore the imperative to improve 
prevention of, detection of and response to public health emergencies, whether 
naturally occurring, deliberate or accidental.] In that respect, we remain 
committed to advancing compliance with the WHO’s IHR objectives including 
through the Global Health Security Agenda (GHSA).  
2016-74 We renew our support to a coordinated approach to offer concrete assistance to 
76 countries and regions and support to these partners to develop national plans 
in close coordination with the WHO and other relevant organizations.  
2016-75 Recognizing the primary responsibility of countries to strengthen their IHR core 
capacities, we intend to assist these partners to achieve the common and 
measurable targets of the Joint External Evaluation (JEE) tool published by the 
WHO and in partnership with other organizations such as the Food and 
Agriculture Organization of the United Nations (FAO) and the World Organization 
for Animal Health (OIE).  
2016-76 We also commit to support, undergo, and share such evaluations with our 
partners.  
2016-77 Attaining of UHC with strong health systems and better preparedness 
Recognizing the importance of accelerating achievement of UHC with the 
principle of no one left behind, we reiterate our commitment to enhance our 
support and coordination to strengthen health systems, especially in developing 
countries, to make them more resilient, inclusive, affordable, sustainable, and 
equitable ones.  
2016-78 we support the establishment of UHC 2030 that seeks to ensure the International 
Health Partnership (IHP+) principles and is supported by initiatives such as the 
Roadmap Healthy Systems, Healthy Lives.  
2016-79 Meanwhile, taking into consideration the pressing need for HSS in Low Income 
Countries (LICs) and Lower Middle Income Countries (LMICs) where health 
systems are especially weak, we are also committed to support country-led HSS 
in collaboration with relevant partners including the WHO.  
2016-80 We are committed to ending AIDS, tuberculosis and malaria, working in 
partnership with the Global Fund (GF) and others.  
2016-81 To this end, we fully support a successful 5th replenishment of the GF, taking the 
opportunity of the GF replenishment conference in Montreal in September, and 
call on traditional and new donors to support the replenishment.  
2016-82 We also commit to promoting active ageing, with due consideration to gender 
specific aspects, through multi-sectoral approaches including the promotion of 
18 
age-friendly communities and support for communities to become dementia-
friendly.   
2016-83 Building on the G7’s previous commitment, we commit to make collective efforts 
for strengthening and actively implementing a multi-sectoral One Health 
Approach, taking into account the sectors including human and animal health, 
agriculture, food and the environment.  
2016-84 We particularly endeavor to preserve effectiveness of antimicrobials, including by 
preserving existing antibiotics, to strengthen the inter-sectoral surveillance in all 
sectors, and to improve access to effective antimicrobials through accelerated 
support in cooperation with other countries and private sector partners.  
2016-85 we also commit to consider potential for new incentives to promote R&D on AMR 
and call on the international community to take further action.  
2016-86 Against those backdrops, we are committed to support the 2016 High-Level 
Meeting on AMR at the UN General Assembly that promotes effective 
implementation of the Global Action Plan through multi-sectoral global, regional, 
national, and community collaborative efforts, and recognize existing initiatives, 
such as those highlighted in the EU Ministerial One Health Conference on AMR, 
the Tokyo Meeting of Health Ministers on AMR in Asia, and the GHSA AMR 
Action Package.  
G7 Ise-Shima Vision for Global Health Commitments 
2016-196 At the G7 Ise-Shima Summit, we, the G7 leaders, commit to take the following 
concrete actions for advancing global health.  
2016-197 In addition to its wider reform agenda, urge and support the WHO to implement 
its reforms for outbreaks and health emergencies, in a timely manner, 
recognizing also its resource needs, with the understanding that the WHO 
should continue to play the central role in global public health crisis 
preparedness and response.  
2016-198 In this relation, (i) renew our support to a coordinated approach to offer concrete 
assistance to 76 countries and regions and support to these partners to develop 
national plans in close coordination with the WHO and other relevant 
organizations;  
2016-199 [recognizing the primary responsibility of countries to strengthen their IHR core 
capacities, intend to assist these partners to achieve the common and 
measurable targets of the Joint External Evaluation (JEE) tool published by the 
WHO and in partnership with other organizations such as the Food and 
Agriculture Organization of the United Nations (FAO) and the World Organization 
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for Animal Health (OIE);] also commit to support, undergo, and share such 
evaluations with our partners,  
2016-200 Therefore, support the establishment of UHC 2030, that seeks to ensure the 
IHP+ principles to accelerate equitable and sustainable progress toward UHC 
through: (i) consolidating political momentum;  
2016-201 [Therefore, support the establishment of UHC 2030, that seeks to ensure the 
IHP+ principles to accelerate equitable and sustainable progress toward UHC 
through:] (ii) creating a common understanding of HSS and UHC;  
2016-202 [Therefore, support the establishment of UHC 2030, that seeks to ensure the 
IHP+ principles to accelerate equitable and sustainable progress toward UHC 
through:] (iii) sharing the common understanding on a minimum set of 
measurable indicators of HSS and UHC drawing from pre-existing ones; and  
2016-203 [Therefore, support the establishment of UHC 2030, that seeks to ensure the 
IHP+ principles to accelerate equitable and sustainable progress toward UHC 
through:] (iv) ensuring accountability by tracking progress toward UHC with these 
indicators, with possible support of initiatives such as the Roadmap Healthy 
Systems, Healthy Lives.  
2016-204 Continue to encourage and support the earliest possible establishment of the 
partnership in consultation with countries, to promote UHC,  
2016-205 [Continue to encourage and support the earliest possible establishment of the 
partnership in consultation with countries] to leverage support for health system 
strengthening in the most vulnerable countries.  
2016-206 Reaffirm our commitment to the SDGs, to leave no one behind, and to ensure 
equity by focusing on the needs of vulnerable segments of society, including the 
poorest and most marginalized populations.  
2016-207 With this in mind and recognizing the pressing need for strong, resilient and 
sustainable health systems in Low Income Countries(LICs) and Lower Middle 
Income Countries(LMICs) with limited resources and increased vulnerability to 
public health threats such as epidemic and other severe events, commit to 
support country-led HSS with greater use of enhanced coordination of country-
level actions toward HSS, based on the IHP+ principles, including through the 
Country Coordination Mechanism of the Global Fund, as well as the GHSA,  
2016-208 Support LICs/LMICs’s nationally driven and owned efforts toward HSS which 
might include the following key contributors for the achievement of UHC with 
better preparedness for and prevention against emergencies; (i) helping the 
development/adjustment of medium-term national health plans;  
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2016-209 [Support LICs/LMICs’s nationally driven and owned efforts toward HSS which 
might include the following key contributors for the achievement of UHC with 
better preparedness for and prevention against emergencies] (ii) strengthening 
policy making and management capacity for disease prevention and health 
promotion;  
2016-210 [Support LICs/LMICs’s nationally driven and owned efforts toward HSS which 
might include the following key contributors for the achievement of UHC with 
better preparedness for and prevention against emergencies] (iii) improving 
access to affordable, safe, effective, and quality assured, essential medicines, 
vaccines and technologies to prevent, diagnose and treat medical problems;  
2016-211 [Support LICs/LMICs’s nationally driven and owned efforts toward HSS which 
might include the following key contributors for the achievement of UHC with 
better preparedness for and prevention against emergencies] (iv) building a 
sufficient capacity of motivated and adequately trained health workers;  
2016-212 [Support LICs/LMICs’s nationally driven and owned efforts toward HSS which 
might include the following key contributors for the achievement of UHC with 
better preparedness for and prevention against emergencies] (v) improving and 
strengthening the quality and use of health statistics and information systems 
including civil registration and vital statistics;  
2016-213 [Support LICs/LMICs’s nationally driven and owned efforts toward HSS which 
might include the following key contributors for the achievement of UHC with 
better preparedness for and prevention against emergencies] (vi) promoting 
access to health services and providing technical support to design health 
financing strategies to provide financial protection against catastrophic out-of-
pocket health expenditures, particularly among the poor;  
2016-214 [Support LICs/LMICs’s nationally driven and owned efforts toward HSS which 
might include the following key contributors for the achievement of UHC with 
better preparedness for and prevention against emergencies] (vii) assisting 
LICs/LMICs’ mobilization of their domestic resources, through both public and 
private sectors, and more efficient health spending as a backbone of sustainable 
national health system; and  
2016-215 [Support LICs/LMICs’s nationally driven and owned efforts toward HSS which 
might include the following key contributors for the achievement of UHC with 
better preparedness for and prevention against emergencies] (viii) monitoring 
progress towards UHC with measurable indicators and share best practices.  
2016-216 Also fully support a successful 5th replenishment of the Global Fund (GF), which 
plays a major role in reducing the impact of significant infectious diseases as well 
as promoting HSS, taking the opportunity of the GF replenishment conference in 
Montreal in September this year, and also call on all traditional and new donors 
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to support the GF achieve its goals and on all countries to increase their 
domestic resources for health.  
2016-217 Use and leverage our commitment to offer support to 76 countries in the 
implementation of the IHR to contribute to resilient and sustainable health 
systems which are able to respond to public health emergencies.  
2016-218 Based on the progress on the G8 Muskoka Initiative, intensify our efforts to 
improving maternal, newborn, child, adolescent health worldwide as upheld in 
the SDGs, with an emphasis on HSS, and also urge increased attention to 
women and adolescent health and to the overall success of the 2030 Agenda.  
2016-219 Increase attention to the need for an integrated approach to the rights and health 
of women and girls, and the importance of closing gaps in universal access to 
physical and mental, as well as to sexual and reproductive health services, 
including for family planning, information and education.  
2016-220 Recognizing the value of taking needs-based responses to health issues for 
women of all ages, including newborns, children, adolescents, as well as those 
in fragile and conflict-affected states and humanitarian settings, commit to: (i) 
provide access to sexual and reproductive health rights and services with a 
focus on adolescent-friendly services and participation;  
2016-221 [Recognizing the value of taking needs-based responses to health issues for 
women of all ages, including newborns, children, adolescents, as well as those 
in fragile and conflict-affected states and humanitarian settings, commit to:] (ii) 
ensuring adequate nutrition with emphasis on the special needs of infants and 
children, and pregnant and lactating mothers, with sharing the G7’s best 
practices; and  
2016-222 [Recognizing the value of taking needs-based responses to health issues for 
women of all ages, including newborns, children, adolescents, as well as those 
in fragile and conflict-affected states and humanitarian settings, commit to:] (iii) 
strengthening the cooperation among the G7’s relevant organizations, making 
the most of their disaster response experiences and drawing upon the Sendai 
Framework on Disaster Risk Reduction 2015-2030.  
2016-223 Reaffirm the importance of immunization as one of key cost-effective measures 
to prevent the spread of infectious disease and address emerging pandemics 
and to this end: (i) continue global efforts to achieve the targets established in 
the Global Vaccine Action Plan;  
2016-224 [Reaffirm the importance of immunization as one of key cost-effective measures 
to prevent the spread of infectious disease and address emerging pandemics 
and to this end:] (ii) leverage and use immunization records including information 
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sources such as Maternal and Child Health(MCH) handbooks which highlight the 
importance of immunization and give guidance to families;  
2016-225 [Reaffirm the importance of immunization as one of key cost-effective measures 
to prevent the spread of infectious disease and address emerging pandemics 
and to this end:] (iii) recognize the tremendous progress achieved towards polio 
eradication where global eradication is now within reach, and reaffirm our 
commitment to achieve polio eradication targets laid out in the GPEI Endgame 
Strategic Plan, and recognize the significant contribution that the polio related 
assets, resources and infrastructure will have on strengthening health systems 
and advancing UHC.  
2016-226 Galvanize international efforts to combat malnutrition and to hold the rise of 
obesity and over-weight targeting most vulnerable populations - mothers, 
children and adolescent girls - and consistent with the WHO Comprehensive 
Implementation Plan on Maternal, Infant and Young Child Nutrition, including: (i) 
the activities within the Decade of Action on Nutrition 2016-2025 and by various 
initiatives such as Scaling Up Nutrition (SUN);  
2016-227 [Galvanize international efforts to combat malnutrition and to hold the rise of 
obesity and over-weight targeting most vulnerable populations - mothers, 
children and adolescent girls - and consistent with the WHO Comprehensive 
Implementation Plan on Maternal, Infant and Young Child Nutrition, including:](ii) 
the Nutrition for Growth Summit.  
2016-228 Work together with WHO and other relevant international actors in the global 
efforts to prevent the spread and reduce the impact of Zika virus, taking account 
scientific consensus that Zika is a cause of microcephaly and other severe fetal 
brain defects in newborns and is associated with an increase in Guillain-Barre 
syndrome and other neurological disorders.  
2016-229 Support the work of global partnerships such as the Global Fund to Fight AIDS, 
Tuberculosis and Malaria, Gavi the Vaccine Alliance, the Global Alliance for 
Chronic Diseases, and UHC 2030 building upon IHP+, as well as global 
initiatives such as the implementation of the Global Strategy for Women’s, 
Children’s and Adolescents’ Health and the GFF as appropriate.  
2016-230 Therefore call for promoting Active Ageing movement both among the G7 and in 
other parts of the world.  
2016-231 Support the WHO’s efforts to develop and implement the Global Strategy and 
Action Plan on Aging and Health, and encourage developing countries and 
transitional countries to make their national and/or regional action plans 
accordingly.  
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2016-232 Pursue multi-sectoral approach to active ageing to reach the highest attainable 
level of well-being, from health care and long-term care to health promotion, 
welfare, employment, pension, housing, and urban/transportation planning, with 
due consideration to gender specific aspects, through such movements as 
promotion of age-friendly communities and support for communities to become 
dementia-friendly, including Age and Dementia-friendly Communities, and 
promoting Dementia Supporters/Friends.  
2016-233 Share knowledge and expertise among and beyond G7 on ways to enhance 
healthy and active ageing and promote a culture of prevention and health, 
welcoming the interim report by the WHO and the OECD on their analyses of 
ways to address challenges related to population ageing.  
2016-234 Building on the previous commitment of the G7 Elmau Summit and its 
subsequent Health Ministers’ Meeting as well as the G7 Niigata Agriculture 
Ministers’ Meeting, promote the One Health Approach to tackle cross-cutting 
issues of AMR in human and animal health, agriculture food and the 
environment, and take actions involving multiple sectors, such as by integrating 
collaboration between the responsible ministries, in line with the 2015 WHO 
Global Action Plan on AMR adopted and relevant resolutions of FAO and OIE.  
2016-235 Strengthen collaboration and support other countries in developing surveillance 
capacity for AMR and antibiotic use in humans, animals, foods and the 
environment and align and/or develop national surveillance systems on AMR in 
line with the WHO Global Antimicrobial Resistance Surveillance System 
(GLASS).  
2016-236 Support the 2016 High-Level Meeting on AMR at the UN General Assembly that 
promotes effective implementation of the Global Action Plan through multi-
sectoral global, regional, national, and community collaborative efforts in 
coordination with WHO, FAO and OIE, including the GHSA AMR Action Package 
and the regional high level political commitments such as the EU Ministerial One 
Health Conference on AMR and the Tokyo Meeting of Health Ministers on AMR 
in Asia, and encourage effective coordination between the multiple initiatives to 
fight AMR.  
2016-237 Support WHO in the implementation of the Global Action Plan on AMR  
2016-238 [Support] other countries in the development and implementation of their national 
action plans on AMR in line with their national health plans.  
2016-239 Recognize effectiveness of antimicrobials as a global public good and prioritize 
efforts to preserving such effectiveness through appropriate and prudent use of 
antimicrobials both in humans and animals, and make efforts to: (i) enhance 
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sharing of information produced by surveillance and/or R&D to guide policies to 
preserve such effectiveness;  
2016-240 [Recognize effectiveness of antimicrobials as a global public good and prioritize 
efforts to preserving such effectiveness through appropriate and prudent use of 
antimicrobials both in humans and animals, and make efforts to:] (ii) promote 
regulatory cooperation, as appropriate, for effective and appropriate control of 
antimicrobial production, prescription, distribution and use both in humans and 
animals through international collaborations;  
2016-241 [Recognize effectiveness of antimicrobials as a global public good and prioritize 
efforts to preserving such effectiveness through appropriate and prudent use of 
antimicrobials both in humans and animals, and make efforts to:] (iii) recognize 
the importance of social and behavioral sciences for addressing key aspects of 
AMR, i.e. inappropriate use of antimicrobials, and raise awareness among 
healthcare providers, patients, veterinarians and animal owners/keepers, and 
general public;  
2016-242 [Recognize effectiveness of antimicrobials as a global public good and prioritize 
efforts to preserving such effectiveness through appropriate and prudent use of 
antimicrobials both in humans and animals, and make efforts to:] (iv) promote 
international cooperation for preserving effectiveness including supporting 
development and implementation of national antimicrobial stewardship program; 
and  
2016-243 [Recognize effectiveness of antimicrobials as a global public good and prioritize 
efforts to preserving such effectiveness through appropriate and prudent use of 
antimicrobials both in humans and animals, and make efforts to:] (v) phase out 
the use of antibiotics for growth promotion in animal husbandry in the absence of 
risk analysis and preserve the use of antibiotics only for therapeutic reasons in 
human and veterinary medicine, noting differences in the G7 member definitions 
of the term antibiotics and referring here to those antibiotics with an impact on 
human health.  
2016-244 While rationalizing use, ensure access to safe, effective and quality-assured 
antimicrobials for humans and animals, including by encouraging international 
discussions on incentivizing the pharmaceutical industry to maintain production 
of essential antibiotics and avoid unavailability or market withdrawals of existing 
antibiotics.  
2016-245 Share with the international community, including the G20, the importance of 
addressing market failure and incentivizing R&D of new antimicrobials, vaccines, 
diagnostics, and alternative therapeutics, and other medical countermeasures in 
human and animal health, building on recent scientific studies and reviews on 
AMR, including the recommendations of the Independent Review on AMR.  
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2016-246 Improve access to effective vaccines, diagnostics, antimicrobials, alternate 
therapeutics.  
2016-247 Support Infection Prevention and Control such as good hygiene - in particular but 
not only in LICs and LMICs to reduce healthcare - associated infections and 
health burden of AMR through appropriate training and technologies, and 
bilateral or multilateral arrangement.  
2016-248 Promote R&D partnerships, and measure the effectiveness of such interventions 
of effective vaccines, diagnostics, antimicrobials, alternate therapeutics, and 
other medical countermeasures as described in 4-1-2.  
2016-249 Shedding light on diseases that require further R&D improvements, particularly 
for conditions not adequately addressed by the market, including Poverty-
Related Infectious Diseases (PRDs) and Neglected Tropical Diseases (NTDs): 
Implement policies to encourage the development of and access to medical 
products for those diseases.  
2016-250 [Shedding light on diseases that require further R&D improvements, particularly 
for conditions not adequately addressed by the market, including Poverty-
Related Infectious Diseases (PRDs) and Neglected Tropical Diseases (NTDs):] 
Encourage G7 countries to support “push (e.g. support to cover R&D cost)” and 
“pull (e.g. making advance purchase and support creating markets/demands)” 
incentives, promote well-coordinated Public-Private Partnership to develop new 
drugs and alternative therapies as exemplified by the Global Health Innovative 
Technology Fund (GHIT) and the Innovative Medicines Initiative (IMI).  
2016-251 [Shedding light on diseases that require further R&D improvements, particularly 
for conditions not adequately addressed by the market, including Poverty-
Related Infectious Diseases (PRDs) and Neglected Tropical Diseases (NTDs):] 
Work to strengthen collaboration between research institutions, funding 
organizations and policy makers across G7 countries, building on the G7-
process for mapping of R&D activities on NTDs and PRDs initiated in 2015 and 
now underway in 2016.  
2016-252 [Shedding light on diseases that require further R&D improvements, particularly 
for conditions not adequately addressed by the market, including Poverty-
Related Infectious Diseases (PRDs) and Neglected Tropical Diseases (NTDs):] 
Encourage regulatory cooperation on pharmaceutical products by participation in 
bodies that develop harmonized standards such as the International Council on 
Harmonisation of Technical Requirements for Pharmaceuticals for Human Use 
(ICH) and International Council on Harmonisation of Technical Requirements for 
Registration of Veterinary Medicinal Products (VICH).  
2016-253 Promote R&D to combat AMR, such as through “pull” incentives to address 
specific market failures and funding for basic and applied research and 
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development of new vaccines, diagnostics, antimicrobials, alternative 
therapeutics as well as IPC, other behavioral interventions, and antimicrobial 
stewardship programs.  
2016-254 Leverage existing global research coordination initiatives such as the Joint 
Programming Initiative on Antimicrobial Resistance (JPIAMR).  
2016-255 Examine efforts to promote globally harmonized clinical trials to support 
development of antimicrobials, diagnostics and other countermeasures, 
especially those against antimicrobial-resistant pathogens and infections, also by 
involving large clinical research infrastructure for the design, coordination and 
conduct of clinical trials and studies.  
2016-256 Promote regulatory cooperation on drugs to facilitate for new antimicrobial 
development.  
2016-257 Explore the feasibility of partnerships such as the Vaccine Innovation for 
Pandemic Preparedness Partnership to conduct a coordinated vaccine research 
and development.  
2016-258 Promote scientifically robust clinical trials on emerging infectious diseases for 
rapid research responses in cases of outbreak.  
2015 (Schloss Elmau, Germany) 
Source: G7 Research Group, 2019 
Leaders’ Declaration 
2015-34 [the G7 commits to putting] the promotion of health [at the centre of our growth 
agenda].  
2015-143 We are therefore strongly committed to continuing our engagement in this field 
with a specific focus on strengthening health systems through bilateral 
programmes.  
2015-144 [We are therefore strongly committed to continuing our engagement in this field 
with a specific focus on strengthening health systems through] multilateral 
structures.  
2015-145 We commit to preventing future outbreaks from becoming epidemics by assisting 
countries to implement the World Health Organization’s International Health 
Regulations (IHR), including through Global Health Security Agenda and its 
common targets and other multilateral initiatives.  
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2015-146 we will offer to assist at least 60 countries, including the countries of West Africa, 
over the next five years, building on countries’ expertise and existing 
partnerships.  
2015-147 We are strongly committed to getting the Ebola cases down to zero.  
2015-148 We support the ongoing process to reform and strengthen the WHO’s capacity to 
prepare for and respond to complex health crises while reaffirming the central 
role of the WHO for international health security.  
2015-149 we will coordinate to fight future epidemics  
2015-150 [we] will set up or strengthen mechanisms for rapid deployment of 
multidisciplinary teams of experts coordinated through a common platform.  
2015-151 We will implement those mechanisms in close cooperation with the WHO and 
national authorities of affected countries.  
2015-152 We will develop or review [our national action plans]  
2015-153 [We will] effectively implement our national action plans.  
2015-154 [We will] support other countries as they develop their own national action plans.  
2015-155 We will foster the prudent use of antibiotics  
2015-156 [We] will engage in stimulating basic research  
2015-157 [We will engage in] research on epidemiology  
2015-158 [We will engage in] infection prevention  
2015-159 [We will engage in infection] control  
2015-160 [We will engage in] the development of new antibiotics  
2015-161 [We will engage in the development of] alternative therapies  
2015-162 [We will engage in the development of] vaccines  
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2015-163 [We will engage in the development of] rapid point-of-care diagnostics.  
2015-164 We commit to taking into account the annex (Joint Efforts to Combat 
Antimicrobial Resistance) as we develop or review [our national action plans].  
2015-165 [We commit to taking into account the annex (Joint Efforts to Combat 
Antimicrobial Resistance) as we] share our national action plans.  
2015-166 We commit ourselves to the fight against neglected tropical diseases (NTDs).  
2015-167 We will work collaboratively with key partners, including the WHO Global 
Observatory on Health Research and Development.  
2015-168 we will contribute to coordinating research and development (R&D) efforts  
2015-169 [We will] make our data available.  
2015-170 We will build on efforts to map current R&D activities, which will help facilitate 
improved coordination in R&D and contribute to better addressing the issue of 
NTDs.  
2015-171 We commit to supporting NTD-related research, focusing notably on areas of 
most urgent need.  
2015-172 we will stimulate both basic research on prevention  
2015-173 [we will stimulate both basic research on] control  
2015-174 [we will stimulate both basic research on] treatment  
2015-175 [we will stimulate] research focused on faster and targeted development of easily 
usable and affordable drugs  
2015-176 [we will stimulate research focused on faster and targeted development of easily 
usable and affordable] vaccines  
2015-177 [we will stimulate] research focused on faster and targeted development of easily 
usable and affordable point-of-care technologies.  
2015-178 As part of our health system strengthening efforts we will continue to advocate 
accessible, affordable, quality and essential health services for all.  
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2015-179 We will invest in the prevention [of NTDs in order to achieve 2020 elimination 
goals].  
2015-180 [We will invest in the] control of NTDs in order to achieve 2020 elimination goals.  
2015-181 We are committed to ending preventable child deaths  
2015-182 [We are committed to] improving maternal health worldwide  
2015-183 We are committed to] supporting the renewal of the Global Strategy for 
Women’s, Children’s and Adolescents’ Health  
Joint Efforts to Combat Antimicrobial Resistance (AMR) 
2015-298 The G7 strongly supports the first Global Action Plan by the World Health 
Organization (WHO) on Antimicrobial Resistance (AMR).  
2015-299 We will develop or review, [our national action plans]  
2015-300 [We will] operationalize [our national action plans]  
2015-301 [We will] share our national action plans  
2015-302 [We will] keep up our cooperation with various organizations and stakeholders 
with a focus on the areas listed below: Combating AMR has to be addressed in a 
two-fold approach: by conserving the effectiveness of existing [antimicrobials]  
2015-303 [We will] [keep up our cooperation with various organizations and stakeholders 
with a focus on the areas listed below: Combating AMR has to be addressed in a 
two-fold approach: by conserving the effectiveness of] future antimicrobials  
2015-304 [We will] [keep up our cooperation with various organizations and stakeholders 
with a focus on the areas listed below: Combating AMR has to be addressed in a 
two-fold approach: by conserving the effectiveness] by engaging in research and 
development for new antimicrobials,  
2015-305 [We will] [keep up our cooperation with various organizations and stakeholders 
with a focus on the areas listed below: Combating AMR has to be addressed in a 
two-fold approach: by conserving the effectiveness by engaging in research and 
development for new] vaccines  
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2015-306 [We will] [keep up our cooperation with various organizations and stakeholders 
with a focus on the areas listed below: Combating AMR has to be addressed in a 
two-fold approach: by conserving the effectiveness by engaging in research and 
development for new] treatment alternatives  
2015-307 [We will] [keep up our cooperation with various organizations and stakeholders 
with a focus on the areas listed below: Combating AMR has to be addressed in a 
two-fold approach: by conserving the effectiveness by engaging in research and 
development for new] rapid diagnostic tools.  
2015-308 We are strongly committed to the One Health approach, encompassing all areas 
of human and animal health as well as agriculture and the environment.  
2015-309 Our national action plans will be based on this concept.  
2015-310 We will specifically foster the prudent use of antibiotics by committing to use 
them for therapeutic reasons under supervision in compliance with national and 
or jurisdictional legislation and after individual diagnosis.  
2015-311 We will increase knowledge [through the implementation of stewardship 
programmes for medical and veterinary professionals as well as livestock 
producers.]  
2015-312 [We will increase] responsible use through the implementation of stewardship 
programmes for medical and veterinary professionals as well as livestock 
producers.  
2015-313 we are committed to intensifying our dialogue with the pharmaceutical [which 
plays a vital role in our close collaboration with the WHO]  
2015-314 [we are committed to intensifying our dialogue with the] biotechnology [the World 
Organisation for Animal Health (OIE)]  
G7 Action Plan to Combat Marine Litter Overarching Principles  
2015-325 [We remain strongly committed to the eradication of] malnutrition. 
2015-331 [We will continue and build upon our existing wide range of interventions for] 
nutrition 
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Appendix B: G20 commitments related to health 
The numbers listed next to each commitment in the tables below are those assigned by the G7 
Research Group at the University of Toronto. 
2019 (Osaka, Japan) 
Source: Warren, 2019 
Leaders' Declaration 
2019-101 We will strengthen health systems with a focus on quality including through 
enhancing health workforce and human resources for policy development 
2019-102 We will strengthen health systems with a focus on quality including through… 
promoting public and private sector innovation, such as cost-effective and 
appropriate digital and other innovative technologies. 
2019-103 We will promote healthy and active ageing through policy measures to address 
health promotion 
2019-104 We will promote healthy and active ageing through policy measures to address… 
prevention and control of communicable and non-communicable diseases 
2019-105 We will promote healthy and active ageing through… people-centered, multi-
sectoral, community-based integrated health and long-term care over the life 
course in accordance with national context including demographic trends. 
2019-106 We will implement comprehensive set of policies to address dementia, including 
promoting risk reduction and sustainable provision of long-term care as well as 
inclusive societies aiming to improve quality of lives of people with dementia and 
caregivers. 
2019-107 We are committed to improving public health preparedness and response including 
strengthening our own core capacities 
2019-108 We are committed to improving public health preparedness and response 
including… supporting capacities of other countries in compliance with the World 
Health Organization (WHO) International Health Regulations (2005). 
2019-109 We will support countries suffering from the current Ebola outbreak in Africa, 
through both timely financial and technical assistance and in line with the central 
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coordination responsibility that WHO has for international responses to health 
emergencies. 
2019-110 We will work for the sustainability and efficiency of global health emergency 
financing mechanisms. 
2019-111 We reaffirm our commitment to eradicate polio 
2019-112 We reaffirm our commitment to… end the epidemics of AIDS, tuberculosis and 
malaria 
2019-113 We will accelerate efforts based on the One-Health approach to tackle antimicrobial 
resistance (AMR). 
2019-114 Noting the ongoing work done by Global AMR R&D Hub, we will promote R&D to 
tackle AMR. 
2018 (Buenos Aires, Argentina) 
Source: Warren, 2018 
Declaration 
2018-46 We will tackle malnutrition, with a special focus on childhood overweight and 
obesity, through national, community-based and collaborative multi-stakeholder 
approaches. 
2018-47 We reaffirm the need for stronger health systems providing cost effective and 
evidence-based intervention to achieve better access to health care and to improve 
its quality and affordability to move towards Universal Health Coverage (UHC), in 
line with their national contexts and priorities. 
2018-48 We will continue to strengthen core capacities required by International Health 
Regulations (IHR, 2005) for prevention, detection and response to public health 
emergencies, while recognizing the critical role played by WHO in this regard. 
2018-49 We are committed to ending HIV/AIDS, tuberculosis and malaria, and look forward 
to a successful 6° replenishment of the Global Fund in 2019. 
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2017 (Hamburg, Germany) 
Source: Warren, 2017 
G20 Leaders' Declaration: Shaping an Interconnected World 
2017-62 we strive for cooperative action to strengthen health systems worldwide, including 
through developing the health workforce.  
2017-63 We strive to fully eradicate polio.  
2017-64 We advocate for sufficient and sustainable funding to strengthen global health 
capacities, including for rapid financing mechanisms and the WHO's Health 
Emergencies Programme.  
2017-65 To tackle the spread of AMR in humans, animals and the environment, we aim to 
have implementation of our National Action Plans, based on a One-Health 
approach, well under way by the end of 2018.  
2017-66 We will promote the prudent use of antibiotics in all sectors  
2017-67 [We] strive to restrict their use in veterinary medicine to therapeutic uses alone  
2017-68 We will strengthen public awareness [of AMR]  
2017-69 [We will strengthen] infection prevention and control [of AMR]  
2017-70 [We will] improve the understanding of the issue of antimicrobials in the 
environment  
2017-71 We will promote access to affordable and quality antimicrobials, vaccines and 
diagnostics, including through efforts to preserve existing therapeutic options.  
2017-72 In collaboration with relevant experts including from the OECD and the WHO, we 
will further examine practical market incentive options  
2017-141 Act in line with our obligations under the International Health Regulations  
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2017-142 support the leadership and coordination of WHO for health crises management. 
(SDG 3)  
2017-143 Continue to contribute to health systems strengthening based on a common 
understanding at national, regional and international levels with relevant partners 
and combine these efforts with requirements of the International Health 
Regulations, with the aim to develop resilient health systems. (SDG 3)  
2017-144 Develop and implement National Action Plans against Antimicrobial Resistance 
applying the One Health approach. (SDG 3)  
2017-291 Support national and international efforts to strengthen sustainable health systems.  
2017-292 Support international efforts, including those of the WHO Health Emergencies 
Program, to manage health risks and crises in a comprehensive way, from 
prevention, preparedness and early identification of disease outbreaks to effective 
response and recovery efforts.  
2017-293 Advance common efforts against anti-microbial resistance by developing evidence-
based ways to prevent resistance  
2017-294 unlock research and development into new and existing antimicrobial medicines 
and diagnostic tools.  
2016 (Hangzhou, China) 
Source: Warren, 2016 
G20 Leaders' Communiqué 
2016-137 We affirm the need to explore in an inclusive manner to fight antimicrobial 
resistance by developing evidence-based ways to prevent and mitigate resistance, 
and unlock research and development into new and existing antimicrobials from a 
G20 value-added perspective, and call on the WHO, FAO, OIE and OECD to 
collectively report back in 2017 on options to address this including the economic 
aspects. 
2016-138 In this context, we will promote prudent use of antibiotics and take into 
consideration huge challenges of affordability and access of antimicrobials and 
their impact on public health. 
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2016-139 We strongly support the work of the WHO, FAO and the OIE and look forward to a 
successful high-level meeting on AMR during the UN General Assembly. 
2015 (Antalya, Turkey) 
Source: Bracht, 2015 
G20 Leaders' Communiqué 
2015-100 We agree that attention should be given to global health risks, such as antimicrobial 
resistance, infectious disease threats and weak health systems. These can 
significantly impact growth and stability. Building on the Brisbane Statement, we 
underscore the importance of a coordinated international response and reiterate 
our resolve to tackle these issues to fight the adverse impacts on the global 
economy 
2015-101 [we] will discuss the terms of reference to deal with this issue in the G20 next year. 
 
 
